In melanoma, tumor-induced plasmablast-like-enriched B cell could maintain tumor inflammation and recruit CD8 + T cells [12], and tumor-associated CD20 + B cells are surrounded by CD4 + T cells, which is associated with improved survival [13]. This evidence concerns the gene MS4A1 and neoplasm.